The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial

Objectives: This study aimed to assess the effects of Liothyronine supplementation on memory performance in patients diagnosed with mood disorders (major depressive or bipolar disorder).Methods: This double-blind controlled clinical trial was conducted on patients with major depression and bipolar d...

Full description

Bibliographic Details
Main Authors: Pooya Hazegh, Fatemeh Sadat Ghoreishi, Fatemeh Assarian, Amir Ghaderi
Format: Article
Language:English
Published: Kashan University of Medical Sciences 2024-02-01
Series:International Archives of Health Sciences
Subjects:
Online Access:http://iahsj.kaums.ac.ir/article_187493_578b94b74c063726fb986cd3ffb9aea0.pdf
_version_ 1827291953578901504
author Pooya Hazegh
Fatemeh Sadat Ghoreishi
Fatemeh Assarian
Amir Ghaderi
author_facet Pooya Hazegh
Fatemeh Sadat Ghoreishi
Fatemeh Assarian
Amir Ghaderi
author_sort Pooya Hazegh
collection DOAJ
description Objectives: This study aimed to assess the effects of Liothyronine supplementation on memory performance in patients diagnosed with mood disorders (major depressive or bipolar disorder).Methods: This double-blind controlled clinical trial was conducted on patients with major depression and bipolar disorder. The participants were randomly assigned to either the intervention group receiving Liothyronine or the placebo group, with 33 patients in each group, for a duration of one month. Memory performance was assessed before the first, fourth, and final ECT sessions, as well as one month after the last session using the Wechsler Memory Scale-Revised (WMS-R). Data analysis was performed using independent-samples Chi-square test and the Greenhouse-Geisser correction factor.Results: Liothyronine significantly enhanced communicative learning and visual memory in patients with major depression and bipolar disorder one month after the final ECT session. Additionally, a positive effect of Liothyronine on immediate recall was observed before the last ECT session.Conclusion: Liothyronine supplementation improves ECT-induced cognitive impairment in patients with major depression and bipolar disorder. Further research is necessary to fully comprehend the potential of Liothyronine as an adjunctive treatment for major depression and bipolar disorder.
first_indexed 2024-04-24T12:47:28Z
format Article
id doaj.art-07dc15a1576445bdb47e4ca88001655e
institution Directory Open Access Journal
issn 2383-2568
language English
last_indexed 2024-04-24T12:47:28Z
publishDate 2024-02-01
publisher Kashan University of Medical Sciences
record_format Article
series International Archives of Health Sciences
spelling doaj.art-07dc15a1576445bdb47e4ca88001655e2024-04-06T16:39:10ZengKashan University of Medical SciencesInternational Archives of Health Sciences2383-25682024-02-01111495510.48307/iahsj.2023.407118.1011187493The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trialPooya Hazegh0Fatemeh Sadat Ghoreishi1Fatemeh Assarian2Amir Ghaderi3Department of Psychiatry, School of Medicine, Kashan University of Medical Science, Kashan, IranDepartment of Psychiatry, School of Medicine, Kashan University of Medical Science, Kashan, IranDepartment of Psychiatry, School of Medicine, Kashan University of Medical Science, Kashan, IranDepartment of Addiction Studies, School of Medicine AND Clinical Research Development Unit, Matini/Kargarnejad Hospital, Kashan University of Medical Sciences, Kashan, IranObjectives: This study aimed to assess the effects of Liothyronine supplementation on memory performance in patients diagnosed with mood disorders (major depressive or bipolar disorder).Methods: This double-blind controlled clinical trial was conducted on patients with major depression and bipolar disorder. The participants were randomly assigned to either the intervention group receiving Liothyronine or the placebo group, with 33 patients in each group, for a duration of one month. Memory performance was assessed before the first, fourth, and final ECT sessions, as well as one month after the last session using the Wechsler Memory Scale-Revised (WMS-R). Data analysis was performed using independent-samples Chi-square test and the Greenhouse-Geisser correction factor.Results: Liothyronine significantly enhanced communicative learning and visual memory in patients with major depression and bipolar disorder one month after the final ECT session. Additionally, a positive effect of Liothyronine on immediate recall was observed before the last ECT session.Conclusion: Liothyronine supplementation improves ECT-induced cognitive impairment in patients with major depression and bipolar disorder. Further research is necessary to fully comprehend the potential of Liothyronine as an adjunctive treatment for major depression and bipolar disorder.http://iahsj.kaums.ac.ir/article_187493_578b94b74c063726fb986cd3ffb9aea0.pdfliothyronineelectroconvulsive therapymemorydepressive disorderbipolar disorder
spellingShingle Pooya Hazegh
Fatemeh Sadat Ghoreishi
Fatemeh Assarian
Amir Ghaderi
The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial
International Archives of Health Sciences
liothyronine
electroconvulsive therapy
memory
depressive disorder
bipolar disorder
title The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial
title_full The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial
title_fullStr The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial
title_full_unstemmed The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial
title_short The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial
title_sort effect of liothyronine supplementation on electroconvulsive therapy induced cognitive impairment in patients with mood disorders a clinical trial
topic liothyronine
electroconvulsive therapy
memory
depressive disorder
bipolar disorder
url http://iahsj.kaums.ac.ir/article_187493_578b94b74c063726fb986cd3ffb9aea0.pdf
work_keys_str_mv AT pooyahazegh theeffectofliothyroninesupplementationonelectroconvulsivetherapyinducedcognitiveimpairmentinpatientswithmooddisordersaclinicaltrial
AT fatemehsadatghoreishi theeffectofliothyroninesupplementationonelectroconvulsivetherapyinducedcognitiveimpairmentinpatientswithmooddisordersaclinicaltrial
AT fatemehassarian theeffectofliothyroninesupplementationonelectroconvulsivetherapyinducedcognitiveimpairmentinpatientswithmooddisordersaclinicaltrial
AT amirghaderi theeffectofliothyroninesupplementationonelectroconvulsivetherapyinducedcognitiveimpairmentinpatientswithmooddisordersaclinicaltrial
AT pooyahazegh effectofliothyroninesupplementationonelectroconvulsivetherapyinducedcognitiveimpairmentinpatientswithmooddisordersaclinicaltrial
AT fatemehsadatghoreishi effectofliothyroninesupplementationonelectroconvulsivetherapyinducedcognitiveimpairmentinpatientswithmooddisordersaclinicaltrial
AT fatemehassarian effectofliothyroninesupplementationonelectroconvulsivetherapyinducedcognitiveimpairmentinpatientswithmooddisordersaclinicaltrial
AT amirghaderi effectofliothyroninesupplementationonelectroconvulsivetherapyinducedcognitiveimpairmentinpatientswithmooddisordersaclinicaltrial